An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Suspected neurological conditions: recognition and referral.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)
Top results in this bookTable of Contents
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Galcanezumab (Emgality): CADTH Reimbursement Review: Therapeutic area: Prevention of migraine [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Mar.
Nocturnal Enuresis: The Management of Bedwetting in Children and Young People.
National Clinical Guideline Centre (UK).
London: Royal College of Physicians (UK); 2010. (NICE Clinical Guidelines, No. 111.)
Cerebral palsy in under 25s: assessment and management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2017 Jan. (NICE Guideline, No. 62.)
Depression in Adults with a Chronic Physical Health Problem: Treatment and Management.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society (UK); 2010. (NICE Clinical Guidelines, No. 91.)
Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2022 Nov 23. (NICE Guideline, No. 228.)
Pain Management [Internet].
Fenske JN, Berland DW, Chandran SK, et al.
Ann Arbor (MI): Michigan Medicine University of Michigan; 2021 Jan.
WHO guideline on school health services [Internet].
Geneva: World Health Organization; 2021.
Headaches in over 12s: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2021 Dec 17. (NICE Guideline, No. 150.)
Atogepant (Qulipta): CADTH Reimbursement Recommendation: Indication: For the prevention of episodic migraine (< 15 migraine days per month) in adults [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jun.
Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families: Updated 2021 [Internet].
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2018. (Treatment Improvement Protocol (TIP) Series, No. 63.)
Substance Use Disorder Treatment for People With Co-Occurring Disorders: Updated 2020 [Internet].
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2020. (Treatment Improvement Protocol (TIP) Series, No. 42.)
Head injury: assessment and early management.
London: National Institute for Health and Care Excellence (NICE); 2023 May 18. (NICE Guideline, No. 232.)
WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings [Internet].
Geneva: World Health Organization; 2023.
Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes.
NICE Medicines and Prescribing Centre (UK).
Manchester: National Institute for Health and Care Excellence (NICE); 2015 Mar. (NICE Guideline, No. 5.)
Coeliac Disease: Recognition, Assessment and Management.
London: National Institute for Health and Care Excellence (NICE); 2015 Sep. (NICE Guideline, No. 20.)
Pitolisant Hydrochloride (Wakix): CADTH Reimbursement Recommendation: Indication: For the treatment of excessive daytime sleepiness or cataplexy in adult patients with narcolepsy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Dec.
Upadacitinib (Rinvoq): CADTH Reimbursement Recommendation: Indication: For the treatment of adults and adolescents 12 years of age and older with refractory moderate to severe atopic dermatitis who are not adequately controlled with a systemic treatment (e.g., steroid or biologic) or when use of those therapies is inadvisable. Upadacitinib can be used with or without topical corticosteroids [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Normal Immunoglobulin (Human) 10% and Recombinant Human Hyaluronidase (HyQvia): CADTH Reimbursement Recommendation: Indication: As replacement therapy for primary humoral immunodeficiency and secondary humoral immunodeficiency in adult patients [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on